Target intelligence / Profile preview

Metaxin-3 (MTX3)

Target
MTX3
Molecular classification
Other (Metaxin-3 is a membrane-associated protein, part of protein complexes in mitochondria, but is not classified within typical therapeutic target families such as receptor, transporter, enzyme, ion channel, etc.[2][6]), Membrane protein, Mitochondrial protein
01

Overview

Metaxin-3 is a mitochondrial membrane-associated protein encoded by the MTX3 gene in humans (HGNC: 24812; NCBI Gene: 345778)[2][5][6]. It is predicted to function in the import and organization of proteins within mitochondria, being part of the mitochondrial intermembrane space bridging (MIB) complex and associated with the sorting and assembly machinery (SAM) complex[2][6]. MTX3 is related to other metaxin family proteins (MTX1, MTX2) and is conserved across vertebrates[1][2]. While genetic studies note disease associations (including rare syndromes), Metaxin-3 is not currently a recognized therapeutic target for drugs or clinical interventions. Its principal role appears structural and organizational within mitochondrial biology, with no established functions in signal transduction, cell cycle, apoptosis, or other major pathways targeted in clinical pharmacology[2][6].

Other names
Metaxin 3MTX3Metaxin-3mtx3
02

Biological functions

Mitochondrion organization[2][3]Protein import into mitochondrion[2][6]Component of mitochondrial intermembrane space bridging (MIB) complex[6]Associated with sorting and assembly machinery (SAM) complex[3]Structural role in mitochondrial membrane[2][6]
03

Disease associations

Other (MTX3 is associated with some Mendelian syndromes, including Transient Arthritis and Loeys-Dietz Syndrome 1, though there is currently limited evidence for its direct involvement or biomarker status in major disease categories like cancer, inflammation, infection, etc.)[2]Transient arthritis[2]Loeys-Dietz Syndrome 1[2]Genetic syndromes (adjacent chromosomal location to disease-associated genes such as THBS4[1])

Beyond the preview

Go deeper on Metaxin-3 (MTX3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metaxin-3 (MTX3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call